CDC study shows effectiveness of RSV immunization for infants
March 7, 2024 9:04AM CST
New data released today in CDC’s MMWR show that nirsevimab, a long-acting monoclonal antibody product, was highly effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV).